Life (Jun 2023)

Association between Mortality and Lung Low Attenuation Areas in NSCLC Treated by Surgery

  • Davide Colombi,
  • Ganiyat Adenike Ralitsa Adebanjo,
  • Rocco Delfanti,
  • Sara Chiesa,
  • Nicola Morelli,
  • Patrizio Capelli,
  • Cosimo Franco,
  • Emanuele Michieletti

DOI
https://doi.org/10.3390/life13061377
Journal volume & issue
Vol. 13, no. 6
p. 1377

Abstract

Read online

Background: to test the association with overall survival (OS) of low attenuation areas (LAAs) quantified by staging computed tomography (CT) of patients who underwent radical surgery for nonsmall-cell lung cancer (NSCLC). Methods: patients who underwent radical surgery for NSCLC at our institution between 1 January 2017 and 30 November 2021 were retrospectively evaluated. Patients who performed staging or follow-up CTs in other institutions, who received lung radiotherapy or chemotherapy, and who underwent previous lung surgery were excluded. At staging and 12-months follow-up CT, LAAs defined as voxels p = 0.038), staging CT %LAAs ≥ 5% (HR, 7.27; 95%CI, 1.60–32.96; p = 0.010), and staging CT %LAA lobe ratio > 10% (HR, 0.24; 95%CI 0.05–0.94; p = 0.046). Conclusions: in patients with NSCLC who underwent radical surgery, a %LAAs ≥ 5% and a %LAA lobe ratio > 10% at staging CT are predictors, respectively, of shorter and longer OS. The LAA ratio to the whole lung at staging CT could be a critical factor to predict the overall survival of the NSCLC patients treated by surgery.

Keywords